MIP Pharma Group Revenue and Competitors
Estimated Revenue & Valuation
- MIP Pharma Group's estimated annual revenue is currently $27.3M per year.
- MIP Pharma Group's estimated revenue per employee is $201,000
Employee Data
- MIP Pharma Group has 136 Employees.
- MIP Pharma Group grew their employee count by 11% last year.
MIP Pharma Group's People
Name | Title | Email/Phone |
---|---|---|
1 | Senior Brand Manager | Reveal Email/Phone |
2 | Controller | Reveal Email/Phone |
3 | Leitung Konfektionierung | Reveal Email/Phone |
4 | IT-Leiter | Reveal Email/Phone |
MIP Pharma Group Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $53.7M | 267 | 16% | N/A | N/A |
#2 | $53.1M | 264 | 21% | N/A | N/A |
#3 | $69.1M | 344 | 26% | N/A | N/A |
#4 | $22.1M | 110 | -10% | N/A | N/A |
#5 | $151.8M | 755 | 11% | N/A | N/A |
#6 | $63.9M | 318 | 13% | N/A | N/A |
#7 | $29.9M | 149 | 13% | N/A | N/A |
#8 | $1.7M | 17 | -6% | $114.3M | N/A |
#9 | $6.8M | 34 | -6% | N/A | N/A |
#10 | $12.5M | 62 | -9% | N/A | N/A |
What Is MIP Pharma Group?
The MIP Pharma Group (MIP Pharma) produces and sells prescription-only generics, specifically antibiotics, over-the-counter medicines and medical devices. The main markets are Germany and Poland and some other Eastern European markets. MIP Pharma has two production facilities in Saarland/Germany. With around 250 employees, MIP Pharma realised a total turnover of more than €40 million during the last business year. Contact: [email protected]
keywords:N/AN/A
Total Funding
136
Number of Employees
$27.3M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
MIP Pharma Group News
2022-04-06 - Deciphering the quality of SARS?CoV?2 specific T?cell ...
The group of participants discharged after infection, ... TNF-?, IFN-?, MIP-1?, MIP-1?, MILLIPLEX MAP Human High Sensitivity T Cell Panel...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $169.1M | 552 | -62% | N/A |